Literature DB >> 22622203

Transoral incisionless fundoplication with EsophyX® for treatment of gastro-oesphageal reflux disease.

Pier Alberto Testoni1, Cristian Vailati.   

Abstract

Gastro-oesphageal reflux disease results primarily from the loss of an effective antireflux barrier, which forms a mechanical barrier against the retrograde movement of gastric content. This review describes the technique of performing a transoral incisionless fundoplication with the EsophyX® device. Transoral incisionless fundoplication reconfigures the tissue so as to establish serosa-to-serosa plications which include the muscular layers, and construct 3-5 cm long valves 200-300° in circumference. The steps of the technique, as well as complications and their management are described in detail, and a recent literature review is also provided. At present, available prospective cohort studies indicate that transoral incisionless fundoplication using the EsophyX® device may be effective in approximately half PPI-responsive gastro-oesphageal reflux disease for up to 3 years' follow-up, without troublesome procedure-related persistent side effects.
Copyright © 2012 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22622203     DOI: 10.1016/j.dld.2012.03.019

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  5 in total

Review 1.  Efficacy of transoral incisionless fundoplication (TIF) for the treatment of GERD: a systematic review with meta-analysis.

Authors:  Xiaoquan Huang; Shiyao Chen; Hetong Zhao; Xiaoqing Zeng; Jingjing Lian; Yujen Tseng; Jie Chen
Journal:  Surg Endosc       Date:  2016-08-05       Impact factor: 4.584

Review 2.  Esophageal motility abnormalities in gastroesophageal reflux disease.

Authors:  Irene Martinucci; Nicola de Bortoli; Maria Giacchino; Giorgia Bodini; Elisa Marabotto; Santino Marchi; Vincenzo Savarino; Edoardo Savarino
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-05-06

3.  Esophgeal Perforation and Bilateral Empyema Following Endoscopic EsophyX Transoral Incisionless Fundoplication.

Authors:  Hawa Edriss; Amal El-Bakush; Kenneth Nugent
Journal:  Clin Endosc       Date:  2014-11-30

4.  Outcomes of endoscopic submucosal dissection for gastroesophageal reflux disease (ESD-G) for medication-refractory gastroesophageal reflux disease: 35 cases underwent ESD-G including 15 cases followed more than 5 years.

Authors:  Kazuhiro Ota; Toshihisa Takeuchi; Yuichi Kojima; Noriaki Sugawara; Shinya Nishida; Taro Iwatsubo; Shimpei Kawaguchi; Satoshi Harada; Satoshi Tokioka; Kazuhide Higuchi
Journal:  BMC Gastroenterol       Date:  2021-11-18       Impact factor: 3.067

5.  Endoscopic treatment of refractory gastroesohageal reflux disease.

Authors:  Won Hee Kim; Pil Won Park; Ki Baik Hahm; Sung Pyo Hong
Journal:  Clin Endosc       Date:  2013-05-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.